Universal and potent chimeric antigen receptor-natural killer (upCAR-NK) cells for B-cell malignancy treatment

被引：0
|
作者：
Kwon, Daekee
Moon, Bo Kyung
Han, Mijung
Lee, Tae-Wook
Lee, Ji-Han
Kang, Kyung-Sun
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1330
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1330
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Chimeric antigen receptor T-cells for B-cell malignancies
    Lichtman, Eben I.
    Dotti, Gianpietro
    TRANSLATIONAL RESEARCH, 2017, 187 : 59 - 82
  • [22] Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
    Schuster, Stephen J.
    Svoboda, Jakub
    Chong, Elise A.
    Nasta, Sunita D.
    Mato, Anthony R.
    Anak, Ozlem
    Brogdon, Jennifer L.
    Pruteanu-Malinici, Iulian
    Bhoj, Vijay
    Landsburg, Daniel
    Wasik, Mariusz
    Levine, Bruce L.
    Lacey, Simon F.
    Melenhorst, Jan J.
    Porter, David L.
    June, Carl H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (26): : 2545 - 2554
  • [23] Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects
    Elahi, Reza
    Heidary, Amir Hossein
    Hadiloo, Kaveh
    Esmaeilzadeh, Abdolreza
    STEM CELL REVIEWS AND REPORTS, 2021, 17 (06) : 2081 - 2106
  • [24] Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects
    Reza Elahi
    Amir Hossein Heidary
    Kaveh Hadiloo
    Abdolreza Esmaeilzadeh
    Stem Cell Reviews and Reports, 2021, 17 : 2081 - 2106
  • [25] AUGMENTATION OF HUMAN B-CELL ACTIVATION BY NATURAL-KILLER (NK) CELLS
    WHALEN, G
    MITCHELL, R
    CUPPS, TR
    KATZ, P
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 256 - 256
  • [26] Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
    Tomuleasa, Ciprian
    Fuji, Shigeo
    Berce, Cristian
    Onaciu, Anca
    Chira, Sergiu
    Petrushev, Bobe
    Micu, Wilhelm-Thomas
    Moisoiu, Vlad
    Osan, Ciprian
    Constantinescu, Catalin
    Pasca, Sergiu
    Jurj, Ancuta
    Pop, Laura
    Berindan-Neagoe, Ioana
    Dima, Delia
    Kitano, Shigehisa
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [27] Significantly targeting rituximab resistant B-cell lymphoma (BL) by anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer (NK) cells.
    Chu, Yaya
    Ayello, Janet
    Yahr, Ashlin
    Katz, Jared
    Lo, Lowrence
    Flowers, Allyson
    Cairo, Mitchell S.
    CANCER RESEARCH, 2013, 73
  • [28] Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
    Cai Zhang
    Yuan Hu
    Weihua Xiao
    Zhigang Tian
    Cellular & Molecular Immunology, 2021, 18 : 2083 - 2100
  • [29] Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
    Zhang, Cai
    Hu, Yuan
    Xiao, Weihua
    Tian, Zhigang
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (09) : 2083 - 2100
  • [30] A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies
    Mickinso, Michael
    Hamad, Nada
    Bryant, Christian E.
    Borthakur, Gautam
    Hosing, Chitra
    Shook, David
    Tan, Joanne
    Rajangam, Kanya
    Liu, Hongtao
    Kennedy, Glen A.
    McSweeney, Peter A.
    Hill, Brian T.
    BLOOD, 2021, 138 : 3868 - +
12345